NRG4 and metabolic dysfunction-associated steatotic liver disease: Nrg4 is shown to protect against type 2 diabetes mellitus and non-alcoholic fatty liver disease because Nrg4 can positively regulate ErbB3 and ErbB4 signaling in hepatocytes and inhibit LXR and SREBP1c, promoting lipogenesis (130).